Patient Advocate (old timer, 2000 posts) Joined: May 2002 Posts: 2,152 | I had one additonal thought after I posted that. If we go with that, we limit our market to survivors. Do we want to do that?
Eileen
---------------------- Aug 1997 unknown primary, Stage III mets to 1 lymph node in neck; rt ND, 36 XRT rad Aug 2001 tiny tumor on larynx, Stage I total laryngectomy; left ND June 5, 2010 dx early stage breast cancer June 9, 2011 SCC 1.5 cm hypo pharynx, 70% P-16 positive, no mets, Stage I
|